Learn about the side effects of Protropin (somatrem), from common to rare, for consumers and healthcare professionals.

Somatrem was first marketed under the brand name Protropin by Genentech in 1985. [2] It differs from endogenous growth hormone by the addition of an extra methionine at the N-terminus [3] [circular reference]. Somatrem has largely been replaced by somatropin, marketed by several companies including by Genentech as the brand Nutropin.

PROTROPIN® Roche . Somatrem . Growth Hormone . Action And Clinical Pharmacology: Somatrem is a polypeptide (methionyl human growth hormone) produced by recombinant DNA technology using the gene for human growth hormone.

Somatropin is a human growth hormone (HGH, hGH) used to treat growth failure, short bowel syndrome, and HIV-associated wasting. Includes side effects, interactions, and indications.

Find patient medical information for somatropin injection on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Introduction to Protropin. Protropin is a recombinant pharmaceutical form of somatrem, a growth hormone (HGH) analog used for the treatment of growth hormone deficiency in children. Developed by Genentech, Protropin was the first biotech product approved for therapeutic use.

The first available rhGH, protropin, was a polypeptide hormone produced by inclusion body recombinant DNA technology. Protropin had 192 amino acids and a molecular weight of 22 kDa.

Protropin is a synthetic (man-made) version of human growth hormone (HGH), a naturally occurring substance thats produced by the pituitary gland which primarily stimulates growth in children. Protropin is approved for use in children who have certain conditions which restrict normal growth and development, such as a growth hormone deficiency ...

2024年11月8日 · Protropin, Nutropin Depot, Saizen, Genotropin Why is Somatrem Prescribed? (Indications) This medication is an analogue of growth hormone, prescribed for growth in children.

Protropin is an injectable, recombinant pharmaceutical that is used to treat children with growth problems stemming from an inability to produce their own growth hormone. Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur.